10x Genomics reported cash from operations of $16.97M and free cash flow of $15.39M for the quarter ended Jun 2026, down 4.1% year over year. This cash flow statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||
| Net Income | -17.17M | -18.45M | -42.41M | -64.46M | -41.91M | -17.21M | -50.75M | -62.41M | -92.99M | -48.95M | -59.95M | -37.90M | -35.75M | -49.03M | -34.36M | 34.54M | -27.47M | -16.25M | -13.47M | -17.93M | ||||||||||||
| Share-based CompensationStock Comp. | 25.95M | 26.90M | 26.05M | 36.31M | 33.51M | 40.97M | 42.10M | 45.70M | 40.23M | 38.92M | 36.13M | 38.49M | 33.59M | 32.54M | 31.08M | 27.56M | 25.26M | 25.22M | 22.64M | 25.62M | ||||||||||||
| Deferred Taxes | ||||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 2.79M | 7.06M | 2.45M | 0.60M | 0.11M | |||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -26.22M | 5.80M | -20.80M | -16.96M | -9.56M | 13.72M | -4.12M | -11.53M | -25.30M | 25.76M | -15.72M | 7.50M | 21.64M | -6.75M | 34.35M | 17.71M | 43.21M | 40.78M | 26.12M | 16.97M | ||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 1.58M | 1.54M | 1.78M | 1.94M | 1.96M | 1.95M | 2.13M | 1.94M | 2.05M | 1.99M | 2.30M | 1.93M | 1.79M | 1.81M | 1.79M | 1.84M | 1.95M | 2.04M | 1.95M | 2.02M | ||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 5.70M | 5.78M | 6.19M | 6.50M | 6.16M | 6.52M | 6.48M | 9.94M | 9.37M | 9.72M | 9.19M | 8.97M | 8.96M | 8.75M | 8.02M | 7.82M | 10.30M | 10.06M | 9.96M | 9.66M | ||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 19.39M | 6.83M | -8.73M | -0.30M | 7.35M | 20.62M | -26.28M | 9.75M | 16.16M | 10.97M | -23.52M | -0.12M | -7.68M | 4.37M | -35.33M | -2.59M | -6.63M | 3.23M | -7.98M | 8.51M | ||||||||||||
| Change in InventoryChange Inventory | 7.13M | 8.78M | 3.74M | 7.37M | 8.66M | 1.43M | 0.45M | 1.86M | -2.57M | -7.61M | 9.94M | 5.20M | 4.26M | -9.62M | -8.06M | -7.03M | -7.29M | -5.58M | -2.70M | -3.00M | ||||||||||||
| Change in Account PayablesChange Payables | 2.48M | -1.11M | 2.88M | 7.39M | -4.18M | -0.22M | -0.78M | 2.10M | -4.12M | -3.21M | 4.58M | 1.12M | 4.34M | -13.40M | -2.55M | 6.04M | -0.20M | -5.42M | 4.78M | 3.29M | ||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 18.40M | 4.47M | -13.28M | 5.28M | 4.84M | 6.50M | -15.13M | 4.82M | 19.47M | 19.15M | -12.67M | 0.55M | -5.01M | 4.40M | -11.74M | 3.93M | -2.12M | 17.59M | -20.96M | 3.12M | ||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 20.23M | 27.62M | 28.14M | 27.22M | 36.57M | 39.73M | 30.67M | -0.75M | 15.24M | 3.45M | 2.91M | 2.88M | 3.89M | 2.72M | 1.89M | 1.58M | 0.69M | 1.78M | 1.60M | 1.59M | ||||||||||||
| Acquisitions | 1.50M | 2.50M | ||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 12.66M | 20.04M | 8.71M | 7.72M | 93.34M | 1.60M | 1.19M | 4.05M | 12.97M | 12.81M | 50.00M | 50.00M | 25.20M | 25.00M | 25.00M | |||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -20.23M | -27.62M | -257.56M | -27.53M | -32.63M | -33.17M | 119.96M | -4.46M | 4.90M | 13.10M | 10.63M | 11.95M | -3.62M | -51.59M | -1.89M | -0.94M | -8.80M | -1.80M | -1.31M | -7.74M | ||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 6.68M | 8.90M | 7.83M | 6.36M | 2.04M | 5.00M | 5.81M | 3.68M | 4.37M | 5.61M | 1.64M | 4.60M | 0.16M | 4.52M | 0.42M | 3.52M | 0.62M | 2.24M | 0.27M | 3.02M | ||||||||||||
| Cash from Financing ActivitiesCash from Financing | 6.68M | 8.90M | 2.42M | 6.36M | 2.04M | 5.00M | -3.41M | 7.10M | 4.37M | 5.61M | 1.64M | 4.60M | 0.16M | 4.52M | 0.42M | 3.52M | 0.62M | 2.24M | -8.42M | 3.02M | ||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | ||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.12M | -0.08M | -0.02M | -0.19M | -0.09M | 0.25M | 0.02M | -0.05M | -0.09M | 0.08M | -0.05M | -0.00M | 0.16M | -0.27M | 0.11M | 0.36M | -0.03M | 0.04M | -0.07M | -0.03M | ||||||||||||
| Change in Cash | -39.64M | -12.99M | -275.96M | -38.32M | -40.24M | -14.20M | 112.44M | -8.94M | -16.11M | 44.55M | -3.50M | 24.04M | 18.34M | -54.09M | 32.99M | 20.65M | 35.00M | 41.26M | 16.32M | 12.23M | ||||||||||||
| Free Cash FlowFCF | -46.44M | -21.81M | -48.94M | -44.18M | -46.14M | -26.01M | -34.79M | -10.77M | -40.54M | 22.31M | -18.64M | 4.62M | 17.75M | -9.46M | 32.46M | 16.13M | 42.53M | 39.00M | 24.52M | 15.39M | ||||||||||||
| Net Cash FlowNCF | -39.76M | -12.91M | -275.94M | -38.13M | -40.16M | -14.45M | 112.42M | -8.89M | -16.03M | 44.47M | -3.46M | 24.05M | 18.18M | -53.82M | 32.88M | 20.29M | 35.03M | 41.21M | 16.39M | 12.26M |